Skip to main content
. 2021 Jun 19;225(12):2067–2076. doi: 10.1093/infdis/jiab317

Figure 3.

Figure 3.

Incidence of solicited local and general adverse events from day 1 to day 7 postvaccination (exposed set). Error bars indicate 95% confidence intervals. Abbreviations: 30 RSVPreF3/60 RSVPreF3/120 RSVPreF3, group receiving 1 dose of the RSV vaccine containing 30, 60, or 120 µg of RSVPreF3 antigen; GI, gastrointestinal; placebo, group receiving 1 dose of placebo; RSV, respiratory syncytial virus.